Testosterone in Bariatric Patients

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 17, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Bariatric Surgery CandidateMale HypogonadismMuscle Loss

Interventions

DRUG

Testosterone Undecanoate

The patients will be randomly assigned to either testosterone or placebo.

Trial Locations (1)

HospitalSWD, Esbjerg

All Listed Sponsors

lead

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER